David A. Lane
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 25, 2019
The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 06, 2019
Defective fibrin deposition and thrombus stability in Bambi-/- mice are mediated by elevated anticoagulant function.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 14, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
Journal: The European respiratory journal
Published: September 22, 2018
A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.
Journal: The Journal of biological chemistry
Published: January 28, 2018
Biphasic activation of complement and fibrinolysis during the human nasal allergic response.
Journal: The Journal of allergy and clinical immunology
Published: October 16, 2017
A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.
Journal: PloS one
Published: July 31, 2017
A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.
Journal: The Journal of biological chemistry
Published: January 13, 2017
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Journal: The Journal of biological chemistry
Published: November 24, 2016
Last Updated: 09/26/2026